about
Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traitsCurcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st centurySelective modulation of P-glycoprotein-mediated drug resistanceBreast cancer-derived microparticles display tissue selectivity in the transfer of resistance proteins to cellsMicroparticles Mediate the Intercellular Regulation of microRNA-503 and Proline-Rich Tyrosine Kinase 2 to Alter the Migration and Invasion Capacity of Breast Cancer Cells.Proteome analysis of multidrug-resistant, breast cancer-derived microparticles.Multiple dosing of simvastatin inhibits airway mucus production of epithelial cells: implications in the treatment of chronic obstructive airway pathologies.Differential pharmacological regulation of drug efflux and pharmacoresistant schizophrenia.Targeting P-glycoprotein for effective oral anti-cancer chemotherapeutics.Glioma microvesicles carry selectively packaged coding and non-coding RNAs which alter gene expression in recipient cellsGender differences in p-glycoprotein expression and function: effects on drug disposition and outcome.Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy?Chronic obstructive pulmonary disease: patho-physiology, current methods of treatment and the potential for simvastatin in disease management.Microparticles and their emerging role in cancer multidrug resistance.Cell-derived microparticles: new targets in the therapeutic management of disease.Cellular communication via microparticles: role in transfer of multidrug resistance in cancer.Anti-tumor activities of lipids and lipid analogues and their development as potential anticancer drugs.An analysis of the therapeutic benefits of genotyping in pediatric hematopoietic stem cell transplantation.Microparticles in cancer: A review of recent developments and the potential for clinical application.Targeting microparticle biogenesis: a novel approach to the circumvention of cancer multidrug resistance.Microparticle drug sequestration provides a parallel pathway in the acquisition of cancer drug resistance.Microparticles mediate MRP1 intercellular transfer and the re-templating of intrinsic resistance pathways.In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisation.Fluticasone uptake across Calu-3 cells is mediated by salmeterol when deposited as a combination powder inhaler.Towards the bioequivalence of pressurised metered dose inhalers 2. Aerodynamically equivalent particles (with and without glycerol) exhibit different biopharmaceutical profiles in vitro.Ciprofloxacin is actively transported across bronchial lung epithelial cells using a Calu-3 air interface cell model.Salbutamol sulfate absorption across Calu-3 bronchial epithelia cell monolayer is inhibited in the presence of common anionic NSAIDs.Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epithelia.ABCB1 (P-glycoprotein) reduces bacterial attachment to human gastrointestinal LS174T epithelial cells.Deposition, diffusion and transport mechanism of dry powder microparticulate salbutamol, at the respiratory epithelia.Modification of disodium cromoglycate passage across lung epithelium in vitro via incorporation into polymeric microparticles.Microparticle-associated nucleic acids mediate trait dominance in cancer.Epithelial profiling of antibiotic controlled release respiratory formulations.Modulation of P-glycoprotein-mediated anticancer drug accumulation, cytotoxicity, and ATPase activity by flavonoid interactions.Characterization of PXR mediated P-glycoprotein regulation in intestinal LS174T cells.Dietary nucleotide supplements in infant formula modify the expression of P-glycoprotein in the intestinal epithelium in vitro.Time- and passage-dependent characteristics of a Calu-3 respiratory epithelial cell model.Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells.Specific reversal of multidrug resistance to colchicine in CEM/VLB(100) cells by Gynostemma pentaphyllum extract.The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells.
P50
Q21245759-5BB9B911-E10B-4BD2-87E5-9E216FA3DEF3Q24630927-7432256B-874A-49B5-ADC4-DE65B7D672A6Q28366597-2AFFEDBF-7C71-4215-AEA8-D8E6FA9D5F75Q28486164-D61B0D30-394B-4799-8083-120F0B71507AQ34048932-71625749-78C0-4C7C-AF3C-C7E1D180B2AEQ34080036-6E39E3CD-7775-4991-81B1-7642CEE43B50Q34615434-DDB7C204-8488-4BCA-8A75-B958EDCEB3CBQ37058837-B5A9DB5C-881E-448D-9391-134F329CAB42Q37089924-D48860D6-E03B-45C6-AAE7-BAA585D6A3CBQ37278908-5EE5743B-61B3-48C9-9B57-0954BB460E77Q37515564-8F9CBA1A-64E4-44FE-BA2B-C09A1AD1764DQ37663392-1D9BBCDE-27B4-4200-8EAC-0BA29C61654EQ37880077-0AF50930-12DF-4714-BCE1-B6724FDD1DBDQ37901204-4AA73631-203C-43A3-8125-0BA88B6B8A7CQ38129981-DC56A368-A46D-4D1D-A66D-F9C863C0DC0DQ38206278-F96EF06C-1022-4268-9CA9-2A138BDD771BQ38325098-34184619-0A59-437D-81B5-DB617A55184CQ38372455-EF3E346A-C05C-4A8D-82D5-0B89FE3CAFEEQ38406571-73B2CC67-36FD-4730-9126-CA0B9F70A7F2Q38906144-A5EEFDBF-0336-475E-9586-B2D93EBFF19CQ39086001-25D3A5A5-259F-48AC-80AD-93DE794D4908Q39115046-361568CE-E178-4688-8A32-7542B7679DC8Q39126354-9BA158AA-7512-432A-B13E-946BBBE303A9Q39135769-261FB5A4-0371-4057-A9CE-AE664A1583ACQ39175773-CB6DA37B-BD72-44D8-A131-521704EF4DC3Q39178955-9C0375C9-AB3C-4A9D-85FA-489F2AFE1EA9Q39195090-EF259149-3E04-4C2A-95A6-D25C109F65AFQ39308123-C6D70571-7F75-4E69-A612-CFC13AA12226Q39334169-C66672F0-F3F7-44A5-8914-317874823FA8Q39350900-407FB2C7-CB3E-47DE-BF88-2561EE9E045BQ39421517-B7397792-B54E-4BE2-A33E-40F2B453E5ABQ39464412-402CBB71-F091-4840-818F-74B3A5AAE699Q39536127-3E588E89-A8AC-4772-B578-BD8BD98C5651Q39565024-4C1AE9FC-3799-40B3-8F99-D7CAC1E96180Q39681285-BEFB3909-D3C2-403F-862C-008814700251Q39695470-527578A6-2DBD-4652-9E37-07808123D02CQ39717640-1E34D4B2-5055-41F2-BF3E-4520374DAEF8Q39860485-4087C6A5-4142-4FCD-A602-82E2CB1F1864Q40064806-397B4238-8561-4D39-9143-0A64C7098FFBQ40320715-2B87EEFE-72FF-47BC-80CE-5FACCFF43E0F
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mary Bebawy
@ast
Mary Bebawy
@en
Mary Bebawy
@es
Mary Bebawy
@fr
Mary Bebawy
@nl
Mary Bebawy
@sl
type
label
Mary Bebawy
@ast
Mary Bebawy
@en
Mary Bebawy
@es
Mary Bebawy
@fr
Mary Bebawy
@nl
Mary Bebawy
@sl
prefLabel
Mary Bebawy
@ast
Mary Bebawy
@en
Mary Bebawy
@es
Mary Bebawy
@fr
Mary Bebawy
@nl
Mary Bebawy
@sl
P106
P1153
6506211522
P21
P31
P496
0000-0003-2606-921X